Professional Documents
Culture Documents
• Weight loss
• NIGHT Sweats
• Itch
• Massive splenomegaly
• Bone marrow failure (infections,
bleeding)
• Risk of ACUTE LEUKAEMIA
• Usually ANAEMIC
• Low/high platelets/WCC
depending on the stage
• BLOOD FILM - leucoerythroblastic
blood film with tear drop cells
MANAGEMENT
1. Supportive care
2. ANEMIA - EPO injections, Transfusions
3. SPLEEN SIZE - Ruxolitinib (JAK2 inhibitor)
4. HIGH PLATELETS/WCC - hydroxycarbamide
5. Allogeneic hematopoietic stem cell transplant
2) ACUTE
MYELOID
LEUKEMIA
DEFINITION
RISK FACTORS
• >45 age
• Myelodysplastic syndromes
• Myeloproliferatuve neoplasms
• Chemo/radiotherapy
• Benzene (painters, petroleum, rubber manufacturers)
TYPES OF AML
• Fatigue
• Lymphadenopathy
• Hepatosplenomegaly
• Weight loss
• Fever
• Recurrent infections
• Bruising and mucosal bleeding
INVESTIGATIONS AND MANAGEMENT
MANAGEMENT
•INDUCTION
1. Combination of CYTRABINE and ANTHRACYCLINE (DAUNORUBICIN)
2. Add TRETINOIN in APML
•
•CONSOLIDATION
1. CHEMOTHERAPY
2. STEM CELL TRANSPLANTATION
2) CHRONIC
MYELOID
LEUKEMIA
DEFINITION
CLINICAL FEATURES
• Asymptomatic
• Splenomegaly
• Vague symptoms : weight loss, bone pains
INVESTIGATIONS AND MANAGEMENT
MANAGEMENT
• FIRST LINE - IMATINIB (tyrosine kinase inhibitors)
• SECOND LINE - NILOTINIB, DASATINIB, BOSUTINIB (TKI)
• THIRD LINE - PONATINIB (more potent, more side effects)
• Monitor BCR-ABL1 fusion transcripts and FBC if not sufficient switch to 2nd line
• 4th LINE - ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANT
3) ACUTE
LYMPHOID
LEUKEMIA
DEFINITION
CLINICAL FEATURES
• Fatigue, fever, recurrent infections
• Lymphadenopathy, Hepatosplenomegaly
• Easy bruising, mucosal bleeding, prolonged bleeding
• Parotid, testicular swelling
• CNS involvement : meningism
INVESTIGATIONS AND MANAGEMENT
MANAGEMENT
• Chemotherapy
• Bone marrow transplant
4) CHRONIC
LYMPHOID
LEUKEMIA
DEFINITION
CLINICAL FEATURES
• Fatigue
• Lymphadenopathy
• Hepatosplenomegaly
• Weight loss
• Fever
• Recurrent infections
• Bruising and mucosal bleeding
INVESTIGATIONS AND MANAGEMENT
MANAGEMENT
• Early disease is monitored
• Chemotherapy in advanced
RICHTER TRANSFORMATION:
Can transform into non-hodgkin
lymphoma, poor prognosis
5) MULTIPLE
MYELOMA
DEFINITION
MANAGEMENT
• CHEMOTHERAPY
• STEM CELL TRANSPLANTATION
• BORTERZOMIB MONOTHERAPY when FIRST RELAPSE
• BISPHOSPHONATES - ZOLEDRONATE (bone protection)
LYMPHOMA
6) NON-
HODGKIN
LYMPHOMA
DEFINITION
• Lymphoproliferative disorder
• Differs from leukemia because mostly affects lymph nodes and extra nodal sites
• Involves T,B,NK cells
• MORE COMMON THAN HL
RISK FACTORS
• >50
• Males
• INFECTIONS
• AUTOIMMUNITY - HASHIMOTOS, SJOGRENS
• IMMUNODEF - HIV
CLINICAL FEATURES
• FBC : leukocytosis/pancytopenia
• Blood film
• Ultrasound of lymph nodes
• Excisional biopsy of lymph nodes : DIAGNOSTIC!!
• Bone marrow biopsy and CT CAP : staging
MANAGEMENT
• CHEMOTHERAPY AND/OR RADIOTHERAPY
• RCHOP REGIMEN in HIGH GRADE - RITUXIMAB, CYCLOPHOSPHAMIDE,
HYDROXYDAUNORUBICIN, ONCOVIN, PREDNISOLONE
7) HODGKIN
LYMPHOMA
DEFINITION Subtype Characteristics Pathology Prognosis
Nodular sclerosing Most common subtype (70%) Nodules of Reed-Sternberg cells and lymphoid tissue Good
separated by sclerosis prognosis
Young females
Cervical or mediastinal
• LYMPHOPROLIFERATIVE lymphadenopathy
EYE NUCLEI THAT RELEASE Lymphocyte rich 5% of cases Reed-Sternberg cells and reactive lymphocytosis BEST
prognosis
• B symptoms
• Lympadenopathy
• Splenomegaly (less common in HL)
• PEL-EBSTEIN FEVER (intermittent every couple of weeks)
• Alcohol-induced lymph node pain
• Pruritus
ANN-ARBOR STAGING
• FBC
• LDH : monitor disease
• Ultrasound and Excisional Biopsy of lymph nodes : DIAGNOSTIC!!
MANAGEMENT
• Chemotherapy:
• An example regimen would be ABVD (doxorubicin, bleomycin, vinblastine and dacarbazine). The number of cycles depends on the severity
• An alternate regimen is BEACOPP: bleomycin, etoposide, adriamycin (doxorubicin), cyclophosphamide, oncovin (vincristine), procarbazine
and prednisolone
• Radiotherapy:
• Usually administered after completing a number of cycles of chemotherapy
• Rituximab:
• This monoclonal antibody targets CD20 on lymphocytes and is used in CD20+ lymphoma, i.e. nodular lymphocyte-predominant HL (atypical)
• It is often used alongside chemotherapy and/or radiotherapy
CHEMOTHERAPY COMPLICATIONS
• NEUTROPENIC SEPSIS
- Neutropenia <0.5 and fever
- Manage with antibiotics (piperacillin and tazobactam) within 60 mins
• A 63-year-old man presents to his GP with persistent back pain. His past medical history includes
pneumonia, cellulitis, and pyelonephritis, all of which occurred over the past year. Upon performing a
systemic inquiry, he mentions he has noticed that he bruises quite easily, and has experienced frequent
fatigue, and increased thirst over the past few months. His blood test shows the following results:
• Given the likely diagnosis, what are the blood test results of this patient likely to show?
• A 23-year-old woman has been recently diagnosed with Hodgkin's lymphoma. She had been feeling
fatigued and was found to have multiple palpable lymph nodes when she originally saw the GP. She
has now seen the oncologist and is told that her lymphoma is stage III.
• A 78-year-old woman presents to her GP with stomach cramps and mid-back pain. Her GP notes she has recently been seen in
the practice 2 months earlier with complaints of tiredness and a normocytic, normochromic anaemia was found. She was
referred on a 2-week wait to gastroenterology and an OGD and colonoscopy found no evidence of gastrointestinal malignancy.
A) Dry tap
• B) Hyperplastic lymphoblasts
• C) Hyperplastic megakaryocytes
• D) Plasma cells
• E) Reticular fibrosis
QUESTION 4
• A 67-year-old man comes in complaining of lethargy, weight loss and night sweats in the last
3 months. As part of his investigation, the man has a bone marrow aspiration which shows an
increase in granulocytes at different stages of maturation under the microscope.
A) Hydroxyurea
• B) Imatinib
• C) Interferon-alpha
• D) Radiotherapy
• E) Steroids
QUESTION 5
• A 34-year-old man is referred to the emergency department by his GP with weakness, bone pain, and
splenomegaly. Over the last few weeks he has been gradually feeling more tired and weak when trying to
carry out his daily activities. On examination, he appears very pale and there are petechiae present on his
lower limbs. Following bone marrow sampling he is diagnosed with acute promyelocytic leukaemia
(APML).
Which of the following would most likely be seen on his blood film?
A) 'Tear-drop' poikilocytes
• B) Auer rods
• C) Smear cells
• D) Spherocytes
• E) Target cells
QUESTION 6
• A 80-year-old man attends his GP complaining of persistent mid-back pain for the past 6 months. This
is described as 7/10 in severity and has recently been preventing him from sleeping at night. Past
medical history is unremarkable aside from stable angina and hypertension. On examination there is
bony tenderness particularly in the thoracic spine and restricted range of movement. Blood tests
reveal a raised corrected calcium level as well as a leucopenia. Which one of the following is the most
appropriate action?
• During your ward round on the paediatric unit you review a 5-year-old Caucasian male who has been admitted for
chemotherapy as he has recently been diagnosed with acute lymphoblastic leukaemia (ALL). His mother worriedly
asks you what his chance of survival is and how you work this out.
On reviewing the patient notes, you see he is on the 95th percentile for weight and the 60th for height. His white cell
count at diagnosis was 12 * 10^9/l and there were no noted T or B cell markers on his blood film.
A) Caucasian
• B) Male sex
• C) Presentation under the age of 5
• D) White cell count over 11 * 10^9/l at diagnosis
• E) Obesity
QUESTION 8
• A 65-year-old man presents with a progressive history of headaches, fatigue and generalised bone pain. Base-
level blood tests are performed and identify normocytic anaemia, raised calcium and renal impairment therefore a
diagnosis of multiple myeloma is suspected.
The patient is admitted for corrects of his electrolyte imbalance and a plan for bone marrow biopsy is considered.
What imaging should be conducted as the first line for this patient’s suspected diagnosis?
A) Skeletal survey
• B) Skull x-ray
• C) Whole-body CT scan
• D) Whole-body MRI scan
• E) Whole-body PET scan
QUESTION 9
• A 27-year-old female of Afro-Caribbean origin presents to the oncology clinic following a referral by her
general practitioner. She has been noticing some lumps on her neck that have been classified as painless,
non-tender, asymmetrical lymphadenopathy. She complains of increasing night sweats and she noticed
some pain when she drinks alcohol.
Given the most likely diagnosis, which one of the following features is associated with a poor prognosis?
A) Afro-Caribbean origin
• B) Alcohol-induced pain
• C) Asymmetrical lymphadenopathy
• D) Female sex
• E) Night sweats
QUESTION 10
• An 80-year-old woman is seen in GP due to weight loss, night sweats and fatigue over the preceding weeks. On
examination, she is pale and palpation of her abdomen reveals hepatosplenomegaly. She has a past medical history of
polycythaemia vera. A full blood count reveals pancytopaenia. Blood film shows a characteristic finding associated with
the new condition.
What characteristic finding on blood film is most associated with this patient's new condition?
A) Heinz bodies
• B) Pencil poikilocytes
• C) Schistocytes
• D) Spherocytes
• E) Tear drop poikilocytes